These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8823538)

  • 1. Nephrotoxicity of antiviral therapies.
    Becker BN; Schulman G
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):375-9. PubMed ID: 8823538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adverse effects of antiviral agents].
    Moriuchi M; Moriuchi H
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():233-41. PubMed ID: 18074544
    [No Abstract]   [Full Text] [Related]  

  • 3. Foscarnet-induced penile ulceration.
    Torres T; Fernandes I; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2011; 20(1):39-40. PubMed ID: 21879205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimising the dosage-limiting toxicities of foscarnet induction therapy.
    Jayaweera DT
    Drug Saf; 1997 Apr; 16(4):258-66. PubMed ID: 9113493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic antiviral drugs used in ophthalmology.
    Teich SA; Cheung TW; Friedman AH
    Surv Ophthalmol; 1992; 37(1):19-53. PubMed ID: 1324532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic diabetes insipidus associated with foscarnet--a case report.
    Conn J; Colman P; Brown G; Street A; Bate K
    J Antimicrob Chemother; 1996 Jun; 37(6):1179-81. PubMed ID: 8836823
    [No Abstract]   [Full Text] [Related]  

  • 7. Foscarnet-induced crystalline glomerulonephritis with nephrotic syndrome and acute renal failure after kidney transplantation.
    Zanetta G; Maurice-Estepa L; Mousson C; Justrabo E; Daudon M; Rifle G; Tanter Y
    Transplantation; 1999 May; 67(10):1376-8. PubMed ID: 10360595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foscarnet-induced hypercalcaemia in AIDS.
    Gayet S; Ville E; Durand JM; Mars ME; Morange S; Kaplanski G; Gallais H; Soubeyrand J
    AIDS; 1997 Jul; 11(8):1068-70. PubMed ID: 9223751
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal tolerance of combined treatment with foscarnet and indinavir.
    Guery B; Katlama C; Bochet M; Deray G
    Nephrol Dial Transplant; 1998 Mar; 13(3):815-6. PubMed ID: 9550685
    [No Abstract]   [Full Text] [Related]  

  • 10. Penile erosions associated with foscarnet therapy in a child.
    Hick RW; Prose N
    Pediatr Dermatol; 2010; 27(3):302-3. PubMed ID: 20609154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of crystals in kidneys of AIDS patients treated with foscarnet.
    Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H
    Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the National Institutes of Health. Progress in AIDS research.
    Wyngaarden JB
    JAMA; 1988 Dec; 260(23):3406. PubMed ID: 2850371
    [No Abstract]   [Full Text] [Related]  

  • 13. Acyclovir-induced nephrotoxicity in a patient with acute retinal necrosis.
    Liu DT; Lee VY; Lam PT; Lam DS
    Hong Kong Med J; 2007 Apr; 13(2):155-6. PubMed ID: 17406046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients.
    Morales JM; Muñoz MA; Fernández Zataraín G; García Cantón C; García Rubiales MA; Andrés A; Aguado JM; Gonzalez Pinto I
    Nephrol Dial Transplant; 1995; 10(6):882-3. PubMed ID: 7566623
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG
    J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the Food and Drug Administration.
    Nightingale SC
    JAMA; 1989 Aug; 262(6):740. PubMed ID: 2545935
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of CMV retinitis.
    Deray G; Katlama C; Jacobs C
    N Engl J Med; 1992 Jun; 326(25):1702. PubMed ID: 1317011
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy.
    Navarro JF; Quereda C; Quereda C; Gallego N; Antela A; Mora C; Ortuno J
    Am J Kidney Dis; 1996 Mar; 27(3):431-4. PubMed ID: 8604715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A penile ulceration in a patient with the acquired immunodeficiency syndrome. Foscarnet-induced penile ulceration.
    Fitzgerald E; Goldman HM; Miller WG; Purcell SM
    Arch Dermatol; 1995 Dec; 131(12):1449, 1452. PubMed ID: 7492139
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
    Jacobson MA; Mills J; Rush J; O'Donnell JJ; Miller RG; Greco C; Gonzales MF
    Arch Neurol; 1988 Oct; 45(10):1090-2. PubMed ID: 2845899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.